Company Sakar Healthcare Limited

SAKAR

INE732S01012

Pharmaceuticals

Business Summary

Sales per Business

Sales per region

Managers

Members of the board

Share class

Shareholders

Company contact information

Sector

Sector Specialty & Advanced Pharmaceuticals

Market Closed - NSE India S.E. Other stock markets 07:43:50 2024-07-15 am EDT			5-day change	1st Jan Change
333.6 ^INR	-0.07%		-3.22%	-16.60%

May. 21	Sakar Healthcare Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2024	CI
Mar. 06	Sakar Healthcare Ltd Receives EU GMP Approval Dated 5th March 2024With A Validity of Three Years from Audited Date	CI

Sakar Healthcare Limited is an India-based pharmaceutical formulations company. The Company is engaged in manufacturing of pharmaceutical products providing liquid orals, cephalosporin tablet, capsule, dry powder syrup, dry powder injections, liquid injectable (SVP) in ampoules, vials & lyophilized injections, oral solid dosages and research & development of above products. The Company's oncology products include oral solid dosage (tablet & capsule), liquid injection, lyophilized injection, active pharmaceutical ingredient (API), CDMO products and CRAMs. The Company's product portfolio includes approximately 175 formulations for the international markets, 292 registered brands under its own name in more than 24 therapeutic areas. It has a presence across the regions of Africa (Anglo & Francophone), SEASIA, CIS, Latin & Central America and in Europe. The Company has set up a research-driven vertically integrated with API for oncology formulation manufacturing unit.

Number of employees: 297

INR in Million	2022	Weight	2023	Weight	Delta
Pharmaceutical Products 100.0 %	1,282	100.0 %	1,334	100.0 %	+4.00%

INR in Million	2022	Weight	2023	Weight	Delta
India 100.0 %	1,282	100.0 %	1,334	100.0 %	+4.00%

Managers	Title	Age	Since
Aarsh Sanjay Shah CEO	Chief Executive Officer	33	12-05-31
Sanjay Surendra Shah CEO	Chief Executive Officer	64	04-03-25
Dharmesh R. Thaker DFI	Director of Finance/CFO	58	21-10-30
Sunil Vasantrao Marathe CTO	Chief Tech/Sci/R&D Officer	-	Nov. 05
Bharat S Soni CMP	Compliance Officer	34	20-10-28

Members of the board	Title	Age	Since
Hemendra Kumar C. Shah BRD	Director/Board Member	72	20-09-27
Shailesh Babubhai Patel BRD	Director/Board Member	63	15-03-31
Ritaben Sanjaybhai Shah FOU	Founder	59	04-03-25
Sanjay Surendra Shah CEO	Chief Executive Officer	64	04-03-25
Khyati Bhavya Shah BRD	Director/Board Member	33	Nov. 05
Prashant C. Srivastav BRD	Director/Board Member	45	15-03-31
Aarsh Sanjay Shah CEO	Chief Executive Officer	33	12-05-31
Vishalakshi Chandramouli BRD	Director/Board Member	-	23-08-31
Sunil Vasantrao Marathe CTO	Chief Tech/Sci/R&D Officer	-	Nov. 05
Jignesh Mukundhbhai Parikh BRD	Director/Board Member	-	Nov. 05

	Vote	Quantity	Free-Float	Company-owned shares	Total Float
Stock A	1	21,749,910	21,532,410 ( 99.00 %)	0	99.00 %

Name	Equities	%	Valuation
Sanjay Surendra Shah 45.56 %	9,908,543	45.56 %	37 M ₹
HBM Partners AG 13.75 %	2,991,311	13.75 %	11 M ₹
Tata Capital (Private Equity) 10.62 %	2,309,910	10.62 %	9 M ₹
HBM Partners AG (Investment Management) 6.897 %	1,500,000	6.897 %	6 M ₹
Shah Aarsh 6.012 %	1,307,500	6.012 %	5 M ₹
Subhash Phootarmal Rathod 2.610 %	567,696	2.610 %	2 M ₹
HI-TECH Chemicals Ltd. 1.839 %	400,000	1.839 %	2 M ₹
Ritaben Sanjaybhai Shah 1.126 %	245,000	1.126 %	923 589 ₹
Shah Ayushi 0.4598 %	100,000	0.4598 %	376 975 ₹

Sakar Healthcare Ltd.

Silver Oaks Comm. Complex 406, Opp. Arun Society

380007, Ahmedabad

+91 79 2658 4655

http://www.sakarhealthcare.com

Healthcare

Pharmaceuticals & Medical Research

Pharmaceuticals

Pharmaceuticals

Specialty & Advanced Pharmaceuticals

	1st Jan change	Capi.
SAKAR HEALTHCARE LIMITED	-16.60%	76.12M
MERCK KGAA	+5.31%	73.13B
KYOWA KIRIN CO. LTD.	+31.01%	10.38B
YUHAN CORPORATION	+41.28%	5.16B
SK BIOPHARMACEUTICALS CO., LTD.	-18.53%	4.73B
SHENYANG XINGQI PHARMACEUTICAL CO.,LTD.	+18.24%	3.81B
SHANGHAI SHYNDEC PHARMACEUTICAL CO., LTD.	+26.86%	2.26B
BETTA PHARMACEUTICALS CO., LTD.	-39.52%	1.88B
CHANGCHUN BCHT BIOTECHNOLOGY CO.	-45.54%	1.77B
VELOXIS PHARMACEUTICALS A/S	-0.50%	1.64B

Specialty & Advanced Pharmaceuticals